Treatment of Nasal Allergy by Nasal Instillation of medicated oil.
Phase 3
- Conditions
- Health Condition 1: J309- Allergic rhinitis, unspecified
- Registration Number
- CTRI/2022/04/042059
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a)Patients having SFAR score �7 will be labelled as patient of Allergic Rhinitis and will be included in stydy.
b)Patients who are fit for Nasya karma i.e. Nasyarha.
c)Patients in the age group of 18-70 years.
d)Patients willing to discontinue their previous medicines regarding allergic rhinitis will be given the gap of 2 week.
Exclusion Criteria
a)Patients who fit in the criteria of Nasya anarha21.
b)Patients who are not willing for nasya.
c)Patients having conditions like Nasal polyps, Carcinomas of nose, Rhinitis with recurrent epistaxis, Acute infective rhinitis, Atrophic rhinitis, Hypertrophic rhinitis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Validation of Nasya efficacy in the management of Allergic rhinitis.Timepoint: 2 weeks and 4 weeks
- Secondary Outcome Measures
Name Time Method Clarification regarding dosing pattern of Charakokta Nasya methodology. <br/ ><br>Timepoint: 2 weeks and 4 weeks <br/ ><br>;Standardization of Charakokta Nasya methodology. <br/ ><br>Timepoint: 2 weeks and 4 weeks